Day: May 15, 2020

Formulary Exclusions Favor Rinvoq Use and Increase Costs

Analysis of the American Rheumatology Network-Trio Health (ARN-Trio) registry finds that AbbVie’s Rinvoq use is increasing rapidly as a proportion of JAK inhibitor use. Rheumatologists are asking, why is use of AbbVie’s Rinvoq increasing so rapidly? Given the higher cost of Rinvoq (annual net price $44,035) and similar safety and efficacy across the JAK inhibitor …

Formulary Exclusions Favor Rinvoq Use and Increase Costs Read More »

Join the ARN-Trio Health Registry, Inform Your Clinical Care and Generate Additional Revenue

American Rheumatology Network (ARN) and Trio Health (Trio) have launched the first rheumatology registry that combines pharmacy dispensing data with electronic medical records (EMR) to provide unparalleled real-world insights into patient experiences and outcomes. The new database includes over 75,000 patients within the ARN’s national network, serving as a comprehensive data solution that combines EMR, …

Join the ARN-Trio Health Registry, Inform Your Clinical Care and Generate Additional Revenue Read More »

Scroll to Top

How Can We Help You?